Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.43 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.43 |
| ▸ | ALPL | P05186 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | POLB | P06746 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | GRK6 | P43250 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | GRM2 | Q14416 | 2/20 | 0.35 |
| ▸ | GRM3 | Q14832 | 2/20 | 0.35 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21934979 | 0.67 | ADORA2A (0.33) | LMNAHPGDADORA2AADORA1 | |
| SCHEMBL4752884 | 0.66 | — | — | |
| SCHEMBL12039946 | 0.66 | HSP90AA1 (0.54) | LMNAMAPTADORA2AADORA1ALDH1A1 | |
| SCHEMBL11511782 | 0.64 | DCUN1D1 (0.67) | HPGDALPLALDH1A1SMN1; SMN2GRK6 | |
| SCHEMBL18922260 | 0.64 | — | — | |
| SCHEMBL21934980 | 0.64 | ADORA2A (0.37) | LMNAHPGDMAPTL3MBTL1ADORA2A | |
| SCHEMBL15999332 | 0.62 | MEN1 (0.41) | ADORA2AADORA1SMN1; SMN2HTT | |
| SCHEMBL11512748 | 0.62 | RAB9A (0.63) | HPGDALPLALDH1A1POLBSMN1; SMN2 | |
| SCHEMBL13150042 | 0.61 | ADORA2A (0.32) | ADORA2AADORA1 | |
| SCHEMBL19219030 | 0.61 | CTH (0.33) | LMNAMAPTADORA2AADORA1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4722199-A1 | AZOLE COMPOUND, METHOD FOR SYNTHESIZING SAID AZOLE COMPOUND, AND USE THEREOF | SHIKOKU CHEMICALS CORPORATION (JP) | 2026-04-08 | — | — | EP | disclosed |
| WO-2024247919-A1 | AZOLE COMPOUND, METHOD FOR SYNTHESIZING SAID AZOLE COMPOUND, AND USE THEREOF | 四国化成工業株式会社 | 2024-12-05 | — | — | WO | disclosed |
| US-11680076-B2 | Triazole silane compound, method for synthesizing said compound and use thereof | SHIKOKU CHEMICALS CORPORATION (JP) | 2023-06-20 | — | — | US | disclosed |
| CN-110475782-B | Triazole silane compound, method for synthesizing the compound, and use thereof | 四国化成工业株式会社 | 2022-05-17 | — | — | CN | disclosed |
| EP-3608327-B1 | TRIAZOLE SILANE COMPOUND, METHOD FOR SYNTHESIZING SAID COMPOUND AND USE THEREOF | SHIKOKU CHEM (JP) | 2022-05-04 | — | — | EP | disclosed |
| EP-3608327-A1 | TRIAZOLE SILANE COMPOUND, METHOD FOR SYNTHESIZING SAID COMPOUND AND USE THEREOF | Shikoku Chemicals Corporation (JP) | 2020-02-12 | — | — | EP | disclosed |
| US-20200031852-A1 | TRIAZOLE SILANE COMPOUND, METHOD FOR SYNTHESIZING SAID COMPOUND AND USE THEREOF | SHIKOKU CHEMICALS CORPORATION (JP) | 2020-01-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11680076-B2 | Triazole silane compound, method for synthesizing said compound and use thereof | CYP51A1, TLK2, SIK2 | LMNA 3218/4885HPGD 3199/4885MAPT 2147/4885 |
| US-20200031852-A1 | TRIAZOLE SILANE COMPOUND, METHOD FOR SYNTHESIZING SAID COMPOUND AND USE THEREOF | SEPTIN8, SIK2, CYP51A1 | LMNA 3722/4885HPGD 3106/4885MAPT 2836/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.